Skip to main content

Table 4 Final EBV status for all 518 analyzable samples

From: Reliability of the Siemens Enzygnost and Novagnost Epstein–Barr Virus assays for routine laboratory diagnosis: agreement with clinical diagnosis and comparison with the Merifluor Epstein–Barr Virus immunofluorescence assay

 

Number

Percent of population

Negative

39

7.5

Acute infection

15

2.9

Past infection

464

89.6

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us